SURMOUNT-4 will address the question of weight regain after stopping the drug: patients who took tirzepatide for 6 months, will be assessed for sustained weight loss one year later (NCT04660643)
TIRZEPATIDE COMMON QUESTIONS ABOUT GLP-1 & GIP Are GLP-1 and GIP therapies researched & tested
How does the PlexusDx Precision Peptide Genetic Test improve treatment outcomes
Liraglutide protects against brain Amyloid-142 accumulation in female mice with early alzheimers disease-like pathology
References For Further Reading (1) D.Gwyer, N.M.Wragg & S.L.Wilson (2019) Gastric pentadecapeptide body protection compound BPC 157 and its role in accelerating musculoskeletal soft tissue healing Cell and Tissue Research Volume 377, pages 153159, 27 March 2019
These findings, although early, spark new hope among weight loss doctors and patients alike